Targeting Lung Tumors with Radioimmunotherapy
Author Information
Author(s): Kennel S J, Boll R, Stabin M, Schuller H M, Mirzadeh S
Primary Institution: Life Sciences Division, Oak Ridge National Laboratory
Hypothesis
Can vascular targeting of α-particle emitter 213Bi effectively treat small metastases in the lung?
Conclusion
The study found that targeting lung tumors with 213Bi significantly reduced tumor burden and extended the lifespan of treated mice.
Supporting Evidence
- The treatment resulted in a dose-dependent destruction of tumors.
- Higher doses led to nearly complete cures of lung tumors.
- Tumors in immunodeficient mice were partially destroyed but ultimately regrew.
- An intact immune function is necessary for complete cure.
Takeaway
Researchers used a special treatment to help mice with lung tumors, and it worked really well to shrink the tumors and help the mice live longer.
Methodology
The study used a model system with mice to test the efficacy of 213Bi delivered via a specific monoclonal antibody.
Limitations
The treatment caused lung fibrosis in some cases, leading to eventual death of the treated animals.
Participant Demographics
The study involved various mouse models, including BALB/c and SCID mice.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website